Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200203478> ?p ?o ?g. }
- W4200203478 abstract "Abstract Background The prognosis of pancreatic cancer (PC) has been improved by new chemotherapy regimens (combination of 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin (FOLFIRINOX) or gemcitabine plus nab-paclitaxel (GnP)). Unfortunately, chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse event of these two regimens. The efficacy of pregabalin for CIPN has been reported in previous studies. However, the efficacy of mirogabalin for CIPN remains unknown. Thus, in this study, we aimed to clarify which drug (mirogabalin or pregabalin) was more valuable for improving CIPN. Methods A total of 163 PC patients who underwent FOLFIRINOX or GnP between May 2014 and January 2021 were enrolled. Among them, 34 patients were diagnosed with CIPN. Thirteen patients were treated with mirogabalin (mirogabalin group), and twenty-one patients were treated with pregabalin (pregabalin group). Treatment efficacy was compared between the two groups. Results In both the mirogabalin group and the pregabalin group, the grade of patients with CIPN at 2, 4, and 6 weeks after the initiation of treatment showed significant improvement compared to the pretreatment grade. Notably, the rate of CIPN improvement was higher in the mirogabalin group than in the pregabalin group (2 weeks: 84.6% (11/13) vs 33.3% (7/21), P value = 0.005; 4 weeks, 6 weeks: 92.3% (12/13) vs 33.3% (7/21), P value = 0.001). Conclusions Although both mirogabalin and pregabalin were effective at improving CIPN, mirogabalin might be a suitable first choice for CIPN in PC patients. Trial registration Not applicable" @default.
- W4200203478 created "2021-12-31" @default.
- W4200203478 creator A5000304117 @default.
- W4200203478 creator A5014869239 @default.
- W4200203478 creator A5026380573 @default.
- W4200203478 creator A5029055634 @default.
- W4200203478 creator A5031416330 @default.
- W4200203478 creator A5035428231 @default.
- W4200203478 creator A5036475624 @default.
- W4200203478 creator A5044196816 @default.
- W4200203478 creator A5046703084 @default.
- W4200203478 creator A5051387686 @default.
- W4200203478 creator A5055817781 @default.
- W4200203478 creator A5056069645 @default.
- W4200203478 creator A5074701210 @default.
- W4200203478 creator A5077087020 @default.
- W4200203478 creator A5091644390 @default.
- W4200203478 date "2021-12-09" @default.
- W4200203478 modified "2023-10-14" @default.
- W4200203478 title "Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients" @default.
- W4200203478 cites W1245310091 @default.
- W4200203478 cites W1522874901 @default.
- W4200203478 cites W1530374458 @default.
- W4200203478 cites W1955000909 @default.
- W4200203478 cites W1967411786 @default.
- W4200203478 cites W1971806112 @default.
- W4200203478 cites W1978048598 @default.
- W4200203478 cites W1993151948 @default.
- W4200203478 cites W2008175324 @default.
- W4200203478 cites W2009965676 @default.
- W4200203478 cites W2017566982 @default.
- W4200203478 cites W2022501291 @default.
- W4200203478 cites W2025633891 @default.
- W4200203478 cites W2027389238 @default.
- W4200203478 cites W2036368100 @default.
- W4200203478 cites W2049899770 @default.
- W4200203478 cites W2057662279 @default.
- W4200203478 cites W2058996445 @default.
- W4200203478 cites W2066289906 @default.
- W4200203478 cites W2073796788 @default.
- W4200203478 cites W2090907917 @default.
- W4200203478 cites W2095545130 @default.
- W4200203478 cites W2101345979 @default.
- W4200203478 cites W2110768657 @default.
- W4200203478 cites W2112474929 @default.
- W4200203478 cites W2115658806 @default.
- W4200203478 cites W2118819514 @default.
- W4200203478 cites W2120678991 @default.
- W4200203478 cites W2121608920 @default.
- W4200203478 cites W2141989757 @default.
- W4200203478 cites W2148454282 @default.
- W4200203478 cites W2151253787 @default.
- W4200203478 cites W2156409369 @default.
- W4200203478 cites W2158499547 @default.
- W4200203478 cites W2165480504 @default.
- W4200203478 cites W2168645047 @default.
- W4200203478 cites W2171950337 @default.
- W4200203478 cites W2226183012 @default.
- W4200203478 cites W2267156748 @default.
- W4200203478 cites W2317504614 @default.
- W4200203478 cites W2480793872 @default.
- W4200203478 cites W2520774580 @default.
- W4200203478 cites W2530631627 @default.
- W4200203478 cites W2548931019 @default.
- W4200203478 cites W2585155747 @default.
- W4200203478 cites W2606472798 @default.
- W4200203478 cites W2637410905 @default.
- W4200203478 cites W2757841320 @default.
- W4200203478 cites W2767407521 @default.
- W4200203478 cites W2777989556 @default.
- W4200203478 cites W2782775232 @default.
- W4200203478 cites W2791425968 @default.
- W4200203478 cites W2792245356 @default.
- W4200203478 cites W2796317885 @default.
- W4200203478 cites W2803537745 @default.
- W4200203478 cites W2807338380 @default.
- W4200203478 cites W2889646458 @default.
- W4200203478 cites W2899604581 @default.
- W4200203478 cites W2912943392 @default.
- W4200203478 cites W2915440687 @default.
- W4200203478 cites W2928824372 @default.
- W4200203478 cites W2936264437 @default.
- W4200203478 cites W2999168705 @default.
- W4200203478 cites W2999417355 @default.
- W4200203478 cites W3022045282 @default.
- W4200203478 cites W3043680095 @default.
- W4200203478 cites W4249522930 @default.
- W4200203478 cites W756354817 @default.
- W4200203478 cites W1951390837 @default.
- W4200203478 doi "https://doi.org/10.1186/s12885-021-09069-9" @default.
- W4200203478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34886831" @default.
- W4200203478 hasPublicationYear "2021" @default.
- W4200203478 type Work @default.
- W4200203478 citedByCount "10" @default.
- W4200203478 countsByYear W42002034782022 @default.
- W4200203478 countsByYear W42002034782023 @default.
- W4200203478 crossrefType "journal-article" @default.
- W4200203478 hasAuthorship W4200203478A5000304117 @default.
- W4200203478 hasAuthorship W4200203478A5014869239 @default.
- W4200203478 hasAuthorship W4200203478A5026380573 @default.